Transasia Bio-Medicals Ltd., a key player in India’s diagnostics and medical devices landscape, has appointed Aditi Pai as its new Chief Financial Officer (CFO), a move that reflects the company’s focus on agile financial leadership amid accelerated growth.
Aditi joined Transasia in February 2024 as Head of Finance, quickly making her mark with strategic foresight, financial rigor, and a sharp understanding of compliance and governance. Her swift rise to CFO highlights her strong alignment with the company’s growth vision and her ability to lead finance functions in dynamic, high-growth sectors.
With over 14 years of cross-industry experience in healthcare, e-commerce, and consulting, Aditi brings a proven track record in financial transformation and business strategy. Prior to Transasia, she held the CFO role at BEWAKOOF.com, where she also led the COSMOS Beauty vertical as Business Head, driving diversification and strengthening financial systems.
Before that, Aditi served as Finance Controller at Purplle.com, where she played a pivotal role in financial restructuring and robust reporting infrastructure. Her earlier stints include senior finance roles at SNC-Lavalin and PwC, where she honed her expertise in audits, compliance, and regulatory frameworks.
Also read – Assurance Intl Appoints Nilesh Garg to Drive Growth
A Chartered Accountant and ACCA diploma holder, Aditi is also an active angel investor, supporting early-stage startups with financial mentorship and strategic insights.
Her appointment as CFO signals Transasia’s commitment to cultivating future-ready leadership as it scales its innovation and global presence in diagnostics and medical technology.
